Influenza vaccine delay

Delays in distribution of influenza vaccine expected this season.

July 31, 2000

NEW YORK, July 28 (Praxis Press) A substantial delay in the distribution of influenza vaccine is anticipated for this year's flu season, according to the Advisory Committee for Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC), and implementation of organized influenza vaccination campaigns should be delayed. Annual vaccination against influenza is the primary means for minimizing serious adverse outcomes from influenza virus infections. But lower than anticipated production yields for this year's influenza A (H3N2) vaccine component and other manufacturing problems are expected to delay the distribution of influenza vaccine for the 2000-01 influenza season in the United States. The ACIP recommends that for the 2000-01 influenza season, implementation of organized influenza vaccination campaigns should be delayed but that routine influenza vaccination activities in clinics, offices, hospitals, nursing homes, and other health-care settings should proceed as normal. They also recommend that provider-specific contingency plans for an influenza vaccine shortage should be developed. They do not make new recommendations for the use of influenza antiviral drugs.


Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science